Updates in Psoriatic Arthritis

Article Sidebar

PDF
Published: Oct 16, 2023
DOI: https://doi.org/10.47191/ijmscrs/v3-i10-33
Keywords:
Psoriatic Arthritis, PsA, Biologic Therapies, JAK Inhibitors, Personalized Medicine, Early Diagnosis, Holistic Care, Comorbidity Management, Research, Autoimmune Disorders.

Main Article Content

Patricia Montzerrat Ursua Tovar
Hospital General Manzanillo, Colima Mexico. SSA
Alejandra Maria Paguaga Morales
Facultad de Ciencias Médicas UNAH, Tegucigalpa, Honduras
Bernardo Sepúlveda Ferrer
Universidad de Monterrey
Nelida Shadai Cabrera Alva
Universidad Autónoma del Estado de Hidalgo
, María Fernanda León González
Hospital General de Zona No.2 IMSS San Luis Potosí
Magdalena Aviles Flores
Universidad Autónoma del Estado de Morelos, UAEM
Yadira Yamile Sánchez Marín
Hospital general de zona 1A Antonio Mucha Macías IMSS, CDMX
Jenny Concepción Collinot Zorrilla
Universidad Anáhuac Xalapa

Abstract

Psoriatic Arthritis (PsA) is a multifaceted autoimmune disorder characterized by the intersection of psoriasis and arthritis. Recent advancements in PsA management have reshaped the landscape of treatment, providing hope for patients with previously limited therapeutic options. Emerging biologic therapies and Janus Kinase (JAK) inhibitors have revolutionized PsA care, offering targeted relief and disease progression slowdown. Personalized medicine has emerged as a key approach, tailoring treatments to individual patient profiles. Early diagnosis remains pivotal, and diagnostic criteria have enhanced accuracy. A holistic approach to care, encompassing therapies, lifestyle modifications, psychosocial support, and comorbidity management, has become integral. Continued research explores novel therapeutic targets, biomarkers for personalized treatment, and long-term safety and efficacy. These advancements underpin the evolving PsA landscape, promoting a better quality of life and improved long-term outcomes for those affected.

Article Details

How to Cite
Patricia Montzerrat Ursua Tovar, Alejandra Maria Paguaga Morales, Bernardo Sepúlveda Ferrer, Nelida Shadai Cabrera Alva, , María Fernanda León González, Magdalena Aviles Flores, Yadira Yamile Sánchez Marín, & Jenny Concepción Collinot Zorrilla. (2023). Updates in Psoriatic Arthritis . International Journal of Medical Science and Clinical Research Studies, 3(10), 2284–2287. https://doi.org/10.47191/ijmscrs/v3-i10-33
Issue
Vol. 3 No. 10 (2023): Volume 03 Issue 10 October 2023
Section
Articles
Creative Commons License

This work is licensed under a Creative Commons Attribution 4.0 International License.

References

I. Mease, P. J. (2011). Psoriatic arthritis: update on pathophysiology, assessment and management. Annals of the Rheumatic Diseases, 70(Suppl 1), i77-i84.

II. Lloyd, P., Ryan, C., & Menter, A. (2012). Psoriatic arthritis: an update. Arthritis, 2012.

III. Chandran, V., Barrett, J., Schentag, C. T., Farewell, V. T., & Gladman, D. D. (2009). Axial psoriatic arthritis: update on a longterm prospective study. The Journal of rheumatology, 36(12), 2744-2750.

IV. Duffin, K. C., Chandran, V., Gladman, D. D., Krueger, G. G., Elder, J. T., & Rahman, P. (2008). Genetics of psoriasis and psoriatic arthritis: update and future direction. The Journal of Rheumatology, 35(7), 1449-1453.

V. Mease, P. (2006). Psoriatic arthritis update. Bulletin of the NYU Hospital for Joint Diseases, 64.

VI. Mease, P. J. (2009). Psoriatic arthritis assessment and treatment update. Current opinion in rheumatology, 21(4), 348-355.

VII. Chimenti, M. S., Triggianese, P., De Martino, E., Conigliaro, P., Fonti, G. L., Sunzini, F.,. & Perricone, R. (2019). An update on pathogenesis of psoriatic arthritis and potential therapeutic targets. Expert Review of Clinical Immunology, 15(8), 823-836.

Most read articles by the same author(s)